|
2023
|
Invention
|
Methods and compositions for treatment of ophthalmic disease. Provided herein are compositions fo... |
|
|
Invention
|
Methods and compounds for modulating huntington's disease.
The present disclosure relates to tra... |
|
|
Invention
|
Methods and compounds for the treatment of genetic disease.
The present disclosure relates to co... |
|
|
Invention
|
Methods and compounds for modulating inherited genetic diseases. The present disclosure relates t... |
|
|
Invention
|
Compounds and methods for treating friedreich's ataxia. fxn, fxn fxn plays an active role. |
|
|
Invention
|
Methods and compounds for modulating huntington's disease. The present disclosure relates to tran... |
|
|
Invention
|
Compounds and methods for treating friedreich's ataxia. xn, xn xn plays an active role. The compo... |
|
2022
|
Invention
|
Process for polyamide synthesis.
The disclosure relates to synthetic methods for producing polya... |
|
|
Invention
|
Process for polyamide synthesis. The disclosure relates to synthetic methods for producing polyam... |
|
|
Invention
|
Methods and compounds for treating friedreich's ataxia.
The present disclosure relates to compou... |
|
|
Invention
|
Methods and compounds for treating friedreich's ataxia. The present disclosure relates to compoun... |
|
|
Invention
|
Methods and compounds for treating friedreich's ataxia. fxn fxn plays an active role. The compoun... |
|
2021
|
Invention
|
Methods and compounds for modulating myotonic dystropy 1.
The present disclosure relates to tran... |
|
|
Invention
|
Methods and compounds for modulating myotonic dystrophy 1. The present disclosure relates to tran... |
|
|
Invention
|
Methods and compounds for the treatment of genetic disease. The present disclosure relates to com... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of degenerative disorders and diseases, ocular diso... |
|
|
Invention
|
Methods and compounds for the treatment of fragile x.
The present disclosure relates to compound... |
|
|
Invention
|
Methods and compounds for the treatment of fragile x. fmr1 fmr2 fmr2, and provides compounds and ... |
|
2020
|
P/S
|
pharmaceutical preparations for the treatment of degenerative disorders and diseases, genetic dis... |
|
2019
|
Invention
|
Methods and compounds for the treatment of genetic disease. dmpk, atxnl, atxn2, atxn.3, cacnala, ... |
|
|
Invention
|
Methods and compounds for the treatment of genetic disease. fxnfxnfxn plays an active role.The co... |
|
|
Invention
|
Methods and compounds for the treatment of genetic disease. orf72orf72orf72plays an active role. ... |
|
|
Invention
|
Methods and compounds for the treatment of genetic disease. cnbpcnbpcnbp plays an active role. |
